Day: November 3, 2020

Recon: Brazil’s Anvisa allows J&J to resume COVID-19 vaccine trial; BMS reports positive Phase III for novel psoriasis drug

Posted 03 November 2020 | By Michael Mezher  Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing.  In Focus: US Experts to review Biogen drug that could be first new Alzheimer’s treatment in decades (Reuters) FDA bars critic from review panel of Biogen’s […]

Five reasons why the Covid-19 pandemic is a failure of Big Data Analytics

<![CDATA[ .myIframe { position: relative; padding-bottom: 65.25%; padding-top: 30px; height: 0; overflow: auto; -webkit-overflow-scrolling:touch; //< The ongoing Covid-19 pandemic was an opportunity to test the current capacity of the much-hyped Big Data Analytics. In April, a Harvard Business Review article entitled “Fighting Coronavirus with Big […]